ATE226083T1 - Verkapselung wasserlöslicher peptide - Google Patents
Verkapselung wasserlöslicher peptideInfo
- Publication number
- ATE226083T1 ATE226083T1 AT99933630T AT99933630T ATE226083T1 AT E226083 T1 ATE226083 T1 AT E226083T1 AT 99933630 T AT99933630 T AT 99933630T AT 99933630 T AT99933630 T AT 99933630T AT E226083 T1 ATE226083 T1 AT E226083T1
- Authority
- AT
- Austria
- Prior art keywords
- encapsulation
- water soluble
- soluble peptides
- peptides
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12165398A | 1998-07-23 | 1998-07-23 | |
| US9391498P | 1998-07-23 | 1998-07-23 | |
| PCT/US1999/014869 WO2000004916A1 (en) | 1998-07-23 | 1999-07-09 | Encapsulation of water soluble peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226083T1 true ATE226083T1 (de) | 2002-11-15 |
Family
ID=26788040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99933630T ATE226083T1 (de) | 1998-07-23 | 1999-07-09 | Verkapselung wasserlöslicher peptide |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1098660B1 (de) |
| JP (1) | JP2002521343A (de) |
| AR (1) | AR019466A1 (de) |
| AT (1) | ATE226083T1 (de) |
| AU (1) | AU4964699A (de) |
| CA (1) | CA2338345A1 (de) |
| DE (1) | DE69903553T2 (de) |
| DK (1) | DK1098660T3 (de) |
| ES (1) | ES2185373T3 (de) |
| NO (1) | NO20010358L (de) |
| PT (1) | PT1098660E (de) |
| RU (1) | RU2216343C2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007001865A (ja) * | 2003-09-16 | 2007-01-11 | Ltt Bio-Pharma Co Ltd | 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤 |
| MY158342A (en) * | 2003-11-14 | 2016-09-30 | Novartis Ag | Pharmaceutical composition |
| JP4872813B2 (ja) * | 2007-06-08 | 2012-02-08 | 栗田工業株式会社 | 透過膜の阻止率向上方法および透過膜処理方法 |
| JP4568335B2 (ja) * | 2008-02-04 | 2010-10-27 | 三洋化成工業株式会社 | 抗体含有溶液コントロール試薬 |
| DE102009033196A1 (de) * | 2009-07-14 | 2011-01-20 | Beiersdorf Ag | Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären |
| JP5655147B2 (ja) * | 2010-08-20 | 2015-01-14 | セルリアン・ファーマ・インコーポレイテッド | 治療用ペプチド−ポリマーの複合体、粒子、組成物および関連の方法 |
| EP2797585A4 (de) * | 2011-12-29 | 2015-10-07 | Latitude Pharmaceuticals Inc | Stabilisierte glucagonnanoemulsionen |
| CN107106659B (zh) | 2014-10-27 | 2022-07-08 | 莱迪杜德制药公司 | 肠胃外胰高血糖素制剂 |
| RU2736590C2 (ru) | 2016-02-16 | 2020-11-18 | Стронгбридж Даблин Лимитед | Велдореотид, обладающий плохой растворимостью в физиологических условиях, для применения при лечении акромегалии, акромегалии со злокачественным новообразованием, экспрессирующих sst-r5 опухолей, диабета 2 типа, гипергликемии и опухолей, связанных с гормонами |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
-
1999
- 1999-07-09 PT PT99933630T patent/PT1098660E/pt unknown
- 1999-07-09 EP EP99933630A patent/EP1098660B1/de not_active Expired - Lifetime
- 1999-07-09 DE DE69903553T patent/DE69903553T2/de not_active Expired - Fee Related
- 1999-07-09 AU AU49646/99A patent/AU4964699A/en not_active Abandoned
- 1999-07-09 JP JP2000560909A patent/JP2002521343A/ja active Pending
- 1999-07-09 DK DK99933630T patent/DK1098660T3/da active
- 1999-07-09 CA CA002338345A patent/CA2338345A1/en not_active Abandoned
- 1999-07-09 AT AT99933630T patent/ATE226083T1/de not_active IP Right Cessation
- 1999-07-09 RU RU2001105088/14A patent/RU2216343C2/ru not_active IP Right Cessation
- 1999-07-09 ES ES99933630T patent/ES2185373T3/es not_active Expired - Lifetime
- 1999-07-23 AR ARP990103637A patent/AR019466A1/es unknown
-
2001
- 2001-01-22 NO NO20010358A patent/NO20010358L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20010358D0 (no) | 2001-01-22 |
| ES2185373T3 (es) | 2003-04-16 |
| DE69903553D1 (de) | 2002-11-21 |
| CA2338345A1 (en) | 2000-02-03 |
| PT1098660E (pt) | 2003-02-28 |
| RU2216343C2 (ru) | 2003-11-20 |
| JP2002521343A (ja) | 2002-07-16 |
| DK1098660T3 (da) | 2003-02-17 |
| NO20010358L (no) | 2001-03-22 |
| EP1098660A1 (de) | 2001-05-16 |
| DE69903553T2 (de) | 2003-06-26 |
| AR019466A1 (es) | 2002-02-20 |
| AU4964699A (en) | 2000-02-14 |
| EP1098660B1 (de) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO982097D0 (no) | Peptider | |
| NO982098D0 (no) | Peptider | |
| ATE259241T1 (de) | Wässrige peptidzubereitung | |
| ATE317854T1 (de) | Hepatitis c inhibitor peptide | |
| DE69722620D1 (de) | Nicht-waessrige protische peptidzubereitungen | |
| ATE396204T1 (de) | Peptide als antiangiogene arzneimittel | |
| NO985680L (no) | Peptidderivater | |
| EP1173467A4 (de) | Von chemokinen abgeleitete synthetische peptide | |
| DE60122873D1 (de) | Therapeutische porenbildende peptide | |
| NO983849L (no) | Peptidderivater | |
| EP1106626A4 (de) | Verfahren zur herstellung normaler glykopeptide | |
| ATE226083T1 (de) | Verkapselung wasserlöslicher peptide | |
| EP1197556A4 (de) | NüTZLICHE POLYPEPTIDE | |
| FR2791348B1 (fr) | POLYPEPTIDE Npt2B | |
| EP1159288A4 (de) | Alpha-conotoxin-peptide | |
| ATE235511T1 (de) | Vielfältig verzweigte peptidkonstruktionen | |
| NO20005547D0 (no) | Myelinbasiske proteinpeptider og anvendelser derav | |
| NO20012283D0 (no) | Koblede peptider | |
| DE69905636D1 (de) | D-Aminoacylase aus Sebekia benihana | |
| NO20013933D0 (no) | Peptider | |
| DE69638206D1 (de) | Antineoplastische Peptide | |
| EP1032586A4 (de) | Hypusin enthaltende peptide | |
| EP1230928A4 (de) | Verwendung von peptid | |
| EP1151100A4 (de) | Tau-conotoxin peptide | |
| NO20006091D0 (no) | Humant protein C-polypeptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1098660 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |